OptimizeRx CorporationOPRXNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 61 | 62 | 72 |
| Gross Profit | 36 | 39 | 43 |
| Operating Income | 0 | -12 | -26 |
| Net Income | 0 | -11 | -18 |
| EBITDA | 2 | -9 | -21 |
| EPS Diluted | 0.02 | -0.64 | -1.03 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 85 | 18 | 14 |
| Total Current Assets | 115 | 99 | 54 |
| Total Assets | 141 | 135 | 183 |
| Total Current Liabilities | 9 | 8 | 18 |
| Total Liabilities | 10 | 9 | 57 |
| Total Equity | 131 | 126 | 127 |
| Total Debt | 0 | 0 | 37 |
| Net Debt | -84 | -18 | 23 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | 1 | 11 | -7 |
| Capital Expenditure | -0 | -0 | -1 |
| Free Cash Flow | 0 | 10 | -8 |
| Stock-Based Comp | 5 | 16 | 14 |
| Net Change in Cash | 74 | -66 | -4 |